These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 38022657)

  • 1. Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates.
    Zhou F; Zhang D
    Front Immunol; 2023; 14():1238649. PubMed ID: 38022657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of tuberculosis vaccines in clinical trials: Current status.
    Méndez-Samperio P
    Scand J Immunol; 2018 Oct; 88(4):e12710. PubMed ID: 30175850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis vaccines: Opportunities and challenges.
    Zhu B; Dockrell HM; Ottenhoff THM; Evans TG; Zhang Y
    Respirology; 2018 Apr; 23(4):359-368. PubMed ID: 29341430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current challenges and opportunities for bacillus Calmette-Guérin replacement vaccine candidates.
    Méndez-Samperio P
    Scand J Immunol; 2019 Oct; 90(4):e12772. PubMed ID: 31055842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subunit Protein Vaccine Delivery System for Tuberculosis Based on Hepatitis B Virus Core VLP (HBc-VLP) Particles.
    Dhanasooraj D; Kumar RA; Mundayoor S
    Methods Mol Biol; 2016; 1404():377-392. PubMed ID: 27076312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis Vaccine Development: Progress in Clinical Evaluation.
    Sable SB; Posey JE; Scriba TJ
    Clin Microbiol Rev; 2019 Dec; 33(1):. PubMed ID: 31666281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development.
    Hu Z; Lu SH; Lowrie DB; Fan XY
    Front Immunol; 2022; 13():895020. PubMed ID: 35812383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing Chimeric Virus-like Particle-based Vaccines for Human Papillomavirus and HIV: Lessons Learned.
    Eto Y; Saubi N; Ferrer P; Joseph J
    AIDS Rev; 2019; 21(4):218-232. PubMed ID: 31834327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-Generation TB Vaccines: Progress, Challenges, and Prospects.
    Zhuang L; Ye Z; Li L; Yang L; Gong W
    Vaccines (Basel); 2023 Jul; 11(8):. PubMed ID: 37631874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major findings and recent advances in virus-like particle (VLP)-based vaccines.
    Mohsen MO; Zha L; Cabral-Miranda G; Bachmann MF
    Semin Immunol; 2017 Dec; 34():123-132. PubMed ID: 28887001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano-Sized Chimeric Human Papillomavirus-16 L1 Virus-like Particles Displaying
    Zhou F; Zhang D
    Viruses; 2023 Oct; 15(10):. PubMed ID: 37896900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Vaccine Candidates against Tuberculosis.
    Li Z; Zheng C; Terreni M; Tanzi L; Sollogoub M; Zhang Y
    Curr Med Chem; 2020; 27(31):5095-5118. PubMed ID: 30474525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel vaccine candidates against Mycobacterium tuberculosis.
    Khoshnood S; Heidary M; Haeili M; Drancourt M; Darban-Sarokhalil D; Nasiri MJ; Lohrasbi V
    Int J Biol Macromol; 2018 Dec; 120(Pt A):180-188. PubMed ID: 30098365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Latest advances in the development of tuberculosis vaccines in global clinical trials: a review].
    Zhou F; Zhang Y; Zhang D
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Mar; 36(2):201-206. PubMed ID: 38857967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's Old and New in Tuberculosis Vaccines for Children.
    Cranmer LM; Cotton MF; Day CL; Nemes E
    J Pediatric Infect Dis Soc; 2022 Oct; 11(Supplement_3):S110-S116. PubMed ID: 36314550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis vaccine development: from classic to clinical candidates.
    Li J; Zhao A; Tang J; Wang G; Shi Y; Zhan L; Qin C
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1405-1425. PubMed ID: 32060754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination Against Tuberculosis With Whole-Cell Mycobacterial Vaccines.
    Scriba TJ; Kaufmann SH; Henri Lambert P; Sanicas M; Martin C; Neyrolles O
    J Infect Dis; 2016 Sep; 214(5):659-64. PubMed ID: 27247343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant live vaccine candidates against tuberculosis.
    Kaufmann SH; Gengenbacher M
    Curr Opin Biotechnol; 2012 Dec; 23(6):900-7. PubMed ID: 22483201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis vaccines: beyond bacille Calmette-Guerin.
    McShane H
    Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2782-9. PubMed ID: 21893541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.